QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), today announced the introduction of its Profiler® Balloon Dilatation Catheter in the U.S. market. This new low profile balloon catheter is indicated for general percutaneous transluminal angioplasty (PTA) of the iliac, femoral, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
